A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis

por Kowalski, Emily N., Qian, Grace, Vanni, Kathleen M.M., Sparks, Jeffrey A.
Publicado 2022

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

por Vanni, Kathleen MM, Patel, Naomi J, DiIorio, Michael, Kowalski, Emily, Qian, Grace, Cook, Claire E, Ritter, Susan Y, Wallace, Zachary S, Sparks, Jeffrey A
Publicado 2022

Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation...

por Vanni, Kathleen M.M., Berliner, Nancy, Paynter, Nina P., Glynn, Robert J., MacFadyen, Jean, Colls, Joshua, Lu, Fengxin, Xu, Chang, Ridker, Paul M., Solomon, Daniel H.
Publicado 2020

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study

por Patel, Naomi J., Wang, Xiaosong, Fu, Xiaoqing, Kawano, Yumeko, Cook, Claire, Vanni, Kathleen M.M., Qian, Grace, Banasiak, Emily, Kowalski, Emily, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Publicado 2023

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study

por Patel, Naomi J., D’Silva, Kristin M., Hsu, Tiffany Y-T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M.M., Zaccardelli, Alessandra, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Publicado 2021

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron

por Kawano, Yumeko, Patel, Naomi J., Wang, Xiaosong, Cook, Claire E., Vanni, Kathleen M.M., Kowalski, Emily N., Banasiak, Emily P., Qian, Grace, DiIorio, Michael, Hsu, Tiffany Y. T., Weinblatt, Michael E., Todd, Derrick J., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study

por Schiff, Abigail E., Wang, Xiaosong, Patel, Naomi J., Kawano, Yumeko, Kowalski, Emily N., Cook, Claire E., Vanni, Kathleen M.M., Qian, Grace, Bade, Katarina J., Saavedra, Alene A., Srivatsan, Shruthi, Williams, Zachary K., Venkat, Rathnam K., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2023

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study

por Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D’Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study

por Di Iorio, Michael, Cook, Claire E., Vanni, Kathleen M.M., Patel, Naomi J., D'Silva, Kristin M., Fu, Xiaoqing, Wang, Jiaqi, Prisco, Lauren C., Kowalski, Emily, Zaccardelli, Alessandra, Martin, Lily W., Qian, Grace, Hsu, Tiffany Y-T., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study

por Qian, Grace, Wang, Xiaosong, Patel, Naomi J., Kawano, Yumeko, Fu, Xiaoqing, Cook, Claire E., Vanni, Kathleen M.M., Kowalski, Emily N., Banasiak, Emily P., Bade, Katarina J., Srivatsan, Shruthi, Williams, Zachary K., Todd, Derrick J., Weinblatt, Michael E., Wallace, Zachary S., Sparks, Jeffrey A.
Publicado 2022